[ad_1]
Fourth dose: the summer wave of Covid-19 has overwhelmed Europe, and Europe tries to run for cover, as it can. In fact, on Monday the European Center for Disease Prevention and Control (Ecdc) and the European Medicines Agency (Ema) they recommended the extension of the fourth dose, or rather the second booster, to all over 60s and frail people. It was followed immediately after the announcement by Minister Roberto Speranza on the start of a new vaccination campaign, formalized by a new one circular. While waiting for the new vaccines, the old ones are fished out, why, how they stressed the current EMA and ECDC vaccines they continue to be a lot effective in reducing severe illness, hospitalization and death. Despite the variants. That’s why, alongside the invitation to extend the audience of candidates to the fourth dosethe invitation to get vaccinated remains valid, by completing the cycle and the recommended doses. That is, the circular reads: whoever has not provided the third dose, recommended for some time, should provide, and do the same who has not yet completed the primary vaccination cycle.
But how will the administration of the fourth dose? Who are the eligible candidates and how are the different regions organizing themselves?
Who is the fourth dose recommended and with which vaccines
Short answer: over 60 and frail subjects. Long answer: over 60 and frail subjects over 12 years of age for which at least 120 days have elapsed since the first booster dose (the third dose) or the last post-booster infection (considering the date from which to count the test date positive). They are considerate fragile and therefore candidates to receive the second booster dose of vaccine are all persons who, from 12 years of age, present the pathologies indicated in the tables attached to the ministerial circular, such as for example people with multiple sclerosis, diabetes, liver cirrhosis, severe anemia, Down syndrome, or who have had a stroke.
Better, they add from EMA and the ECDC, for now give priority to those who received the first booster more than six months ago, and reasonably need to reinvigorate the immune response. As well as the frail over 80 and over 60 already previously eligible but still waiting, underlines the ministerial circular. Obviously for now without waiting for the arrival of the new vaccines. The vaccines with which to proceed with the second booster are therefore the already known products based on mRna from Pfizer and Moderna for adults and Pfizer for children between 12 and 17 years of age.
.
[ad_2]
Source link
